GREG ZANTE

Insider Reports History

Location
Richmond, CA
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GREG ZANTE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. Chief Financial Officer Common Stock, par value $0.00001 per share 189,891 $6,093,355 $32.09 05 Jan 2026 Direct
Viking Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 91,000 02 Jan 2026 Direct

Insider Reports Filed by GREG ZANTE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VKTX Viking Therapeutics, Inc. 02 Jan 2026 7 -$1,896,969 4 Chief Financial Officer 05 Jan 2026, 20:31
VKTX Viking Therapeutics, Inc. 27 Oct 2025 2 -$216,481 4 Chief Financial Officer 28 Oct 2025, 19:47
VKTX Viking Therapeutics, Inc. 02 Jul 2025 2 -$118,428 4 Chief Financial Officer 03 Jul 2025, 15:31
VKTX Viking Therapeutics, Inc. 03 Jan 2025 5 -$2,150,595 4 Chief Financial Officer 06 Jan 2025, 20:14
VKTX Viking Therapeutics, Inc. 28 Oct 2024 16 -$9,384,882 4 Chief Financial Officer 28 Oct 2024, 21:48
VKTX Viking Therapeutics, Inc. 29 Jul 2024 5 -$922,212 4 Chief Financial Officer 31 Jul 2024, 16:05
VKTX Viking Therapeutics, Inc. 03 May 2024 8 -$4,819,723 4 Chief Financial Officer 03 May 2024, 20:51
VKTX Viking Therapeutics, Inc. 27 Mar 2024 2 -$1,384,277 4 Chief Financial Officer 27 Mar 2024, 20:50
VKTX Viking Therapeutics, Inc. 01 Mar 2024 2 -$1,712,325 4 Chief Financial Officer 04 Mar 2024, 19:50
VKTX Viking Therapeutics, Inc. 03 Jan 2024 7 -$1,380,965 4 Chief Financial Officer 04 Jan 2024, 21:35
VKTX Viking Therapeutics, Inc. 17 Apr 2023 3 -$51,975 4 Chief Financial Officer 18 Apr 2023, 19:07
VKTX Viking Therapeutics, Inc. 11 Apr 2023 14 -$1,216,506 4 Chief Financial Officer 13 Apr 2023, 17:13
VKTX Viking Therapeutics, Inc. 30 Mar 2023 14 -$2,829,824 4 Chief Financial Officer 03 Apr 2023, 19:24
VKTX Viking Therapeutics, Inc. 30 Dec 2022 6 -$563,422 4 Chief Financial Officer 04 Jan 2023, 17:25
VKTX Viking Therapeutics, Inc. 03 Jan 2022 4 -$55,931 4 Chief Financial Officer 05 Jan 2022, 18:13
VKTX Viking Therapeutics, Inc. 28 Sep 2021 2 -$14,989 4 Chief Financial Officer 30 Sep 2021, 17:43